by Lance Smith | Oct 23, 2019 | Study Scavenger Clinical Trial Recruitment Platform
Segal Trials, a privately held network of research sites throughout South Florida and South Carolina conducting Phase I–IV trials, has been named one of seven sites to begin a Phase II study of psilocybin—a psychedelic prodrug compound—for major depressive disorder...by Lance Smith | Oct 23, 2019 | Study Scavenger Clinical Trial Recruitment Platform
A clinical trial in which healthy adults will be deliberately infected with influenza virus under carefully controlled conditions is recruiting volunteers at four Vaccine and Treatment Evaluation Units (VTEUs) supported by the National Institute of Allergy and...by Lance Smith | Oct 23, 2019 | Study Scavenger Clinical Trial Recruitment Platform
Steven Loab for Vator writes: Clinical trials are one of the most important parts of the healthcare process. Not only are they used to discover potential new treatments for diseases, they can also help in finding ways to detect and diagnose those diseases. Clinical...by Lance Smith | Oct 23, 2019 | Study Scavenger Clinical Trial Recruitment Platform
Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients, today announced the initiation of FREEDOM-1, the...by Lance Smith | Oct 23, 2019 | Study Scavenger Clinical Trial Recruitment Platform
A clinical trial in which healthy adults will be deliberately infected with influenza virus under carefully controlled conditions is recruiting volunteers at four Vaccine and Treatment Evaluation Units (VTEUs) supported by NIH’s National Institute of Allergy and...by Lance Smith | Oct 23, 2019 | Study Scavenger Clinical Trial Recruitment Platform
FibroGen, Inc., (NASDAQ: FGEN), today announced the dosing of the first patient in the LAPIS Phase 3 clinical study of pamrevlumab in patients with unresectable locally advanced pancreatic cancer (LAPC). “Patients with unresectable locally advanced pancreatic cancer...